Yahoo Finance Robert Duggan Is The Independent Chairman of the Board of Pulse Biosciences, Inc. (NASDAQ:PLSE) And They Just Picked Up 25% More Shares
Those following along with Pulse Biosciences, Inc. (NASDAQ:PLSE) will no doubt be intrigued by the recent purchase of shares by Robert Duggan, Independent Chairman of the Board of the company, who spent a stonking US$50m on stock at an average price of US$16.40. Not only is that a big swing, but it increased their holding size by 25%, which is definitely great to see.
Check out our latest analysis for Pulse Biosciences
Pulse Biosciences Insider Transactions Over The Last Year
In fact, the recent purchase by Robert Duggan was the biggest purchase of Pulse Biosciences shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of US$17.25. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the Pulse Biosciences insider decided to buy shares at close to current prices. Robert Duggan was the only individual insider to buy shares in the last twelve months.
You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Pulse Biosciences insiders own 63% of the company, currently worth about US$285m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
So What Do The Pulse Biosciences Insider Transactions Indicate?
The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Pulse Biosciences. Nice! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 3 warning signs that you should run your eye over to get a better picture of Pulse Biosciences.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
